Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for limbic encephalitis with DPP6 antibodies.
5 publications have been identified in PubMed for limbic encephalitis with DPP6 antibodies. Research spans Review / Meta-Analysis (40%), Case Report / Case Series (40%), and Basic Science / Preclinical (20%).
Milano C (2025). [PMID: 40680249](https://pubmed.ncbi.nlm.nih.gov/40680249/). *Neurol Neuroimmunol Neuroinflamm*. [Case Report / Case Series]
Li EC (2025). [PMID: 39693598](https://pubmed.ncbi.nlm.nih.gov/39693598/). *Neurol Neuroimmunol Neuroinflamm*. [Review / Meta-Analysis]
Guasp M (2025). [PMID: 39893022](https://pubmed.ncbi.nlm.nih.gov/39893022/). *Med Clin North Am*. [Review / Meta-Analysis]
Foglia M (2024). [PMID: 39453535](https://pubmed.ncbi.nlm.nih.gov/39453535/). *Cell Mol Life Sci*. [Basic Science / Preclinical]
Santos AB (2024). [PMID: 39347234](https://pubmed.ncbi.nlm.nih.gov/39347234/). *Cureus*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:51 AM UTC
European rare disease database